The Association of the British Pharmaceutical Industry (ABPI) have formed a new Patient Advisory Council including eight leaders from across the patient and health charity sector.
The new Council will bring together industry and patient advocates to help bring the patient voice to the ABPI’s plans to ensure a more patient-centred future strategy, policy, and priorities.
The new members are:
- Charlotte Augst from National Voices
- Emily Crossley from Duchenne UK
- Jane Lyons from Cancer52
- Dr Tom Nutt from Meningitis Now
- Hilary Reynolds from the Association of Medical Research Charities
- Jayne Spink from Prostate Cancer Research
- Bob Stevens from the MPS Society
- Neil Tester from the Richmond Group.
The Patient Advisory Council members will join the ABPI’s Board meeting on 7 September for the first time.
Announcing the first members of the Council, Colette Goldrick, Executive Director of Strategy, Research & Partnerships at the ABPI, said:
“We have had an overwhelming response to our search for a new Patient Advisory Council, and we are really proud to name these eight passionate experts as our inaugural members. Each is a leader in their community, and we are really looking forward to hearing what they have to say and how we can work together towards meaningful change.”
Ben Osborn, President of the ABPI, said:
“The Council was formed with the sole purpose of ensuring the Association, our Board and the industry at large has a greater understanding of the patient experience, and how our work can help improve the lives of patients and their families. We’re excited to get started.”
Council members will provide patient perspectives across topics relevant to both the pharmaceutical industry and patients, such as outcomes-focused healthcare, medicines pricing, patient engagement in health technology assessment (HTA), healthcare data, and collaboration.